DIAGNUM Workstation for mammography by FENICS.


October 13, 2009 - FENICS has validated the Matrox Xenia PRO display controller board with their DIAGNUM Workstation mammography computer-aided detection (CAD) solutions, which will be demonstrating this technology at Journee Française de Radiologie (JFR) 2009 from October 16-20, 2009, in Paris - Porte Maillot, France.

FENICS is the first company from France to propose a set of aided diagnosis solutions for mammography through its DIAGNUM product line. Its DIAGNUM Look solution is an interactive CAD that detects anomalies that also routes and characterizes them to generate reports in the current language. With its strong performance and user friendly interface, the workstation has already attracted the attention of many radiologists.
Matrox Xenia a native PCI Express single-slot board with all-digital, triple-monitor output, and the flexibility that drives display configurations. Xenia Series supports resolutions from under 1MP to 8MP, with up to 1GB of on-board memory, and features new technology to ensure optimum display calibration (via Matrox DLC and 8/10/13-bit gamma LUTs).
Xenia Series is an expandable solution, that provides medical imaging developers and integrators to increase hardware-accelerated performance via hardware LUTs, multiple hardware window IDs, and additional hardware features.
For more information: www.matrox.com/graphics and www.fenics-sas.com


Additional Content

News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
Subscribe Now